Revolutionizing Health with AI & Synthetic Biology

We are at the forefront of integrating artificial intelligence and synthetic biology to transform how therapeutics are discovered and manufactured. Our proprietary technology accelerates the identification of novel metabolite-based interventions, enabling faster, more precise drug discovery.

Additionally, advanced synthetic biology techniques allow us to manufacture critical biomolecules sustainably, eliminating reliance on scarce natural resources.

Two of our initial focus areas include:

A New Class of Neuroprotective Lipids

Neurisy™

Plasmalogens are critical phospholipids found in the brain, heart, and immune cells, essential for neuroprotection, mitochondrial function, and metabolic regulation. However, they decline significantly with age, accelerating cognitive decline, cardiovascular disease, and metabolic dysfunction.

Despite their importance, previous attempts to supplement plasmalogens have failed, as existing precursors are poorly absorbed and do not increase brain plasmalogen levels. Component Health has developed Neurisy™, the first plasmalogen precursor capable of directly raising plasmalogen levels in the brain. This technology represents a paradigm shift in neuroprotection, with potential applications in Alzheimer’s disease, cognitive aging, and metabolic health.

A Versatile Exogenous Ketone Platform

Qitone™

Qitone™ is a next-generation metabolic intervention that serves as a direct precursor to ketone bodies, supporting brain function, energy metabolism, and cellular resilience. Component Health is developing Qitone™ as both an immediate market opportunity and a foundation for an advanced portfolio of novel exogenous ketones.

This platform will support metabolic optimization, endurance, cognitive performance, and aging-related metabolic resilience.